Woehlck H J, Vicenzi M N, Bosnjak Z J, Atlee J L
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee 53226.
Anesthesiology. 1993 Dec;79(6):1304-15. doi: 10.1097/00000542-199312000-00022.
Supraventricular dysrhythmias are common during anesthesia, but have been incompletely investigated. Mechanisms may involve altered automaticity of subsidiary pacemakers and participation of vagal reflexes. The following hypotheses were tested: (1) shifts from the sinoatrial (SA) node to subsidiary pacemakers require intact vagal reflexes and (2) halothane sensitizes the heart to epinephrine-induced atrial pacemaker shifts.
Epicardial electrodes were implanted in eight dogs on both atrial appendages, the right ventricle, along the sulcus terminalis, and at the His bundle. Weekly testing awake (control), awake with atropine methylnitrate, with 1 and 2 micrograms epinephrine.kg-1.min-1 (3 min-infusions), and under 1.25 and 2 MAC halothane was performed. Electrograms were analyzed for the site of earliest activation (SEA), which was scored 1-6 depending on the distance from the SA node, and expressed as the SEA value.
In conscious dogs (control) and at 1.25 MAC halothane, epinephrine increased the SEA values (shifted activation from SA node) and blood pressure, and decreased heart rate; however, with atropine, SEA values were unaffected by epinephrine, although blood pressure and heart rate were elevated. At 2 MAC, atropine did not affect the epinephrine-induced increase in SEA values. Halothane increased SEA values when combined with 1 micrograms epinephrine.kg-1.min-1.
Pacemaker shifts account for atrial dysrhythmias in the conscious state and during 1.25 MAC halothane with epinephrine, and require vagal participation. Halothane sensitizes the heart to epinephrine-induced atrial dysrhythmias. Atropine and halothane facilitate His bundle beats during exposure to epinephrine.
室上性心律失常在麻醉期间很常见,但尚未得到充分研究。其机制可能涉及附属起搏点自动性的改变和迷走反射的参与。对以下假设进行了测试:(1)从窦房结(SA)到附属起搏点的转变需要完整的迷走反射,以及(2)氟烷使心脏对肾上腺素诱导的心房起搏点转变敏感。
在八只狗的心外膜电极植入双侧心耳、右心室、沿着终沟以及希氏束处。每周进行清醒(对照)、清醒时使用硝酸甲基阿托品、使用1和2微克肾上腺素·千克⁻¹·分钟⁻¹(3分钟输注)以及在1.25和2最低肺泡有效浓度(MAC)氟烷下的测试。分析心电图以确定最早激动部位(SEA),根据其与窦房结的距离评分为1 - 6,并表示为SEA值。
在清醒犬(对照)和1.25 MAC氟烷时,肾上腺素增加SEA值(激动从窦房结移位)和血压,并降低心率;然而,使用阿托品时,尽管血压和心率升高,但SEA值不受肾上腺素影响。在2 MAC时,阿托品不影响肾上腺素诱导的SEA值增加。氟烷与1微克肾上腺素·千克⁻¹·分钟⁻¹联合使用时增加SEA值。
起搏点移位是清醒状态下以及在氟烷1.25 MAC联合肾上腺素时心房心律失常的原因,且需要迷走神经参与。氟烷使心脏对肾上腺素诱导的心房心律失常敏感。在暴露于肾上腺素期间,阿托品和氟烷促进希氏束搏动。